China’s second human CRISPR trial is now underway. Soon, the U.S. will be conducting its first trial. The first one to try may not be as relevant; who succeeds will be what matters.
Using this method, they can eliminate many diseases and birth "defects" such as Down Syndrome. But ethically, should they?